metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Brushing your teeth may be good for your liver: Linking oral health to non-alcoh...
Journal Information
Share
Share
Download PDF
More article options
Full text access
Brushing your teeth may be good for your liver: Linking oral health to non-alcoholic fatty liver disease
Visits
1422
Yusuf Yilmaz
Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey
This item has received
Received 05 August 2023. Accepted 15 September 2023
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

The study by Pischke et al. [1], which explores the relationships between non-alcoholic steatohepatitis (NASH) and periodontitis, warrants commendation. The analysis involved 32 patients with NASH and 100 randomly, sequentially gathered, controls from a local dental clinic. The results revealed a markedly higher incidence of periodontitis among those with NASH. Additionally, liver stiffness measurement (LSM) through transient elastography (TE) had a significant correlation with an increase in specific periodontal parameters such as pocket-probing-depths and bleeding-on-probing. Most notably, the study found that the progression of NASH could be potentially tempered through regular oral health care. Consequently, hepatologists should emphasize to their patients the significance of periodic dental check-ups [1]. Here, we would like to underline the critical role of toothbrushing in maintaining oral health among patients with non-alcoholic fatty liver disease (NAFLD). This routine self-care behavior [2] has been recently demonstrated to have significant implications in a study from our group [3]. Our research revealed that patients with NAFLD who brushed their teeth less than once daily had a notably higher prevalence of LSM values equal to or above 12 kPa, a key indicator of hepatic cirrhosis. Furthermore, we discovered an independent association between less frequent toothbrushing and a TE-established diagnosis of cirrhosis in NAFLD [3]. In a separate investigation, Chen and colleagues [4] discovered a correlation between tooth loss and an elevated risk of both NAFLD and liver cancer. Their findings indicated that for every increase of five in tooth loss, there was a corresponding 5% rise in liver cancer risk, suggesting a linear relationship. Furthermore, the study also pointed to a positive correlation between tooth loss and the risk of liver cirrhosis [4]. These findings collectively underscore Pischke et al.’s perspective [1] that hepatologists should emphasize the importance of regular dental visits. Moreover, patients with NAFLD should be encouraged to maintain oral hygiene by brushing their teeth at least twice daily. Intriguingly, Tanaka et al. [5] suggested a decrease in the risk of developing metabolic syndrome (MetS) – a primary risk factor for NAFLD [6] – with an increase in daily toothbrushing frequency, irrespective of periodontal status. More recently, Yamamoto et al. [7] discovered a relation between frequent toothbrushing and a reduced risk of NAFLD. The connections between toothbrushing habits, oral hygiene, periodontitis, and the severity of NAFLD are biologically plausible, yet their exact foundations remain elusive. In Pischke et al.’s study [1], the correlation between NASH and periodontitis was independent of the presence of specific oral bacteria, such as Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. The relationship between oral health behaviors and NAFLD could be tied to broader components of health and socioeconomic status [8]. Another possibility may involve cognitive function. Recent research indicates that NAFLD correlates with diminished cognitive performance across several areas [9], and tooth loss is linked to a significantly elevated risk of cognitive decline [10]. To fully comprehend the complex interplay between oral and liver health, more studies are needed, especially those utilizing the new nomenclature framework set to replace the current NAFLD definition [11–14].

Declaration of Competing Interest

None.

References
[1]
S Pischke, A Shiprov, U Peters, J Schulze Zur Wiesch, J Kluwe, T Westphal, et al.
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity.
[2]
S Kumar, J Tadakamadla, NW. Johnson.
Effect of toothbrushing frequency on incidence and increment of dental caries: a systematic review and meta-analysis.
J Dent Res, 95 (2016), pp. 1230-1236
[3]
C Keklikkiran, M Stepanova, Z Younossi, Y. Yilmaz.
Can frequent toothbrushing reduce the risk of cirrhosis among patients with non-alcoholic fatty liver disease? Hints from a registry-based study.
[4]
Y Chen, YC Yang, BL Zhu, CC Wu, RF Lin, X. Zhang.
Association between periodontal disease, tooth loss and liver diseases risk.
J Clin Periodontol, 47 (2020), pp. 1053-1063
[5]
A Tanaka, K Takeuchi, M Furuta, T Takeshita, S Suma, T Shinagawa, et al.
Relationship of toothbrushing to metabolic syndrome in middle-aged adults.
J Clin Periodontol, 45 (2018), pp. 538-547
[6]
P Almeda-Valdés, D Cuevas-Ramos, CA Aguilar-Salinas.
Metabolic syndrome and non-alcoholic fatty liver disease.
Ann Hepatol, 8 (2009), pp. S18-S24
[7]
K Yamamoto, T Ikeya, S Okuyama, K Fukuda, D Kobayashi.
Association between the frequency of daily toothbrushing and development of nonalcoholic fatty liver disease.
Dig Dis, 39 (2021), pp. 646-652
[8]
EHG de Lucena, RO da Silva, ML Barbosa, ECF de Araújo, AC Pereira, YW. Cavalcanti.
Influence of socioeconomic status on oral disease burden: a population-based study.
BMC Oral Health, 21 (2021), pp. 608
[9]
K Kjærgaard, ACD Mikkelsen, CW Wernberg, LL Grønkjær, PL Eriksen, MF Damholdt, et al.
Cognitive dysfunction in non-alcoholic fatty liver disease – current knowledge, mechanisms and perspectives.
J Clin Med, 10 (2021), pp. 673
[10]
L Li, Q Zhang, D Yang, S Yang, Y Zhao, M Jiang, et al.
Tooth loss and the risk of cognitive decline and dementia: a meta-analysis of cohort studies.
[11]
ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, et al.
A multi-society Delphi consensus statement on new fatty liver disease nomenclature.
[12]
ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, et al.
A multi-society Delphi consensus statement on new fatty liver disease nomenclature.
[13]
ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, et al.
A multi-society Delphi consensus statement on new fatty liver disease nomenclature.
[14]
Y. Yilmaz.
The heated debate over NAFLD renaming: an ongoing saga.
Hepatol Forum, 4 (2023), pp. 89-91
Copyright © 2023. Fundación Clínica Médica Sur, A.C.
Download PDF
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos